您当前所在的位置:首页 > 产品中心 > 产品详细信息
2016-88-8 分子结构
点击图片或这里关闭

3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide hydrochloride

ChemBase编号:72807
分子式:C6H9Cl2N7O
平均质量:266.08796
单一同位素质量:265.0245633
SMILES和InChIs

SMILES:
c1(c(nc(c(n1)C(=O)NC(=N)N)N)N)Cl.Cl
Canonical SMILES:
NC(=N)NC(=O)c1nc(Cl)c(nc1N)N.Cl
InChI:
InChI=1S/C6H8ClN7O.ClH/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11;/h(H4,8,9,13)(H4,10,11,14,15);1H
InChIKey:
ACHKKGDWZVCSNH-UHFFFAOYSA-N

引用这个纪录

CBID:72807 http://www.chembase.cn/molecule-72807.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide hydrochloride
IUPAC传统名
amiloride hydrochloride
amilorida hydrochloride
3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide hydrochloride
别名
Midamor
Colectril
Amipramizide
Amiloride hydrochloride
3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide hydrochloride
Amipramidin
Amipramizid
Amiprazidine
Guanamprazin
Guanamprazine
Amiloride hydrochloride
3,5-Diamino-N-(aminoiminomethyl)-6-chloro-2-pyrazinecarboxamide Hydrochloride
3,5-Diamino-N-(aminomethyl)-6-chloropyrazinecarboxamide
N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride
AMILORIDE
N-Amidino-3,5-diamino-6-chlorocyrazinecarboxamide Monohydrochloride
N-Amidino-3,5-diamino-6-chloropyrazinamide Hydrochloride
Amipramidine
Amiprazide
Nilurid
CAS号
2016-88-8
EC号
217-958-2
PubChem SID
162037728
PubChem CID
16230

理论计算性质

理论计算性质

JChem
Acid pKa 11.426196  质子受体
质子供体 LogD (pH = 5.5) -0.7251268 
LogD (pH = 7.4) -0.4992728  Log P -0.49543247 
摩尔折射率 67.1812 cm3 极化性 19.563002 Å3
极化表面积 156.79 Å2 可自由旋转的化学键
里宾斯基五规则 true 

分子性质

分子性质

理化性质 安全信息 药理学性质 产品相关信息 生物活性(PubChem)
溶解度
DMSO expand 查看数据来源
Methanol expand 查看数据来源
外观
Pale Yellow Solid expand 查看数据来源
熔点
285-288°C expand 查看数据来源
295-297°C (dec.) expand 查看数据来源
保存条件
-20°C expand 查看数据来源
Refrigerator, Under Inert Atmosphere expand 查看数据来源
Room Temperature (15-30°C) expand 查看数据来源
RTECS编号
UQ2275500 expand 查看数据来源
欧盟危险性物质标志
有害性(Harmful) 有害性(Harmful) (Xn) expand 查看数据来源
MSDS下载
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
危险公开号
R:22 expand 查看数据来源
安全公开号
S:46-36/37/39 expand 查看数据来源
生物活性机理
Amiloride exerts its potassium sparing effect through the inhibition of sodium reabsorption at the distal convoluted tubule, cortical collecting tubule and collecting duct; expand 查看数据来源
Amiloride is not an aldosterone antagonist and its effects are seen even in the absence of aldosterone. expand 查看数据来源
Inhibitor of sodium reabsorption in the distal convoluted tubules and collecting ducts in the kidneys by binding to the amiloride-sensitive sodium channels. expand 查看数据来源
this decreases the net negative potential of the tubular lumen and reduces both potassium and hydrogen secretion and their subsequent excretion. expand 查看数据来源
This promotes the loss of sodium and water from the body, but without depleting potassium. expand 查看数据来源
成盐信息
HCl expand 查看数据来源
hydrochloride expand 查看数据来源
质检报告
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
应用领域
Potassium-sparing diuretic expand 查看数据来源

详细说明

详细说明

MP Biomedicals MP Biomedicals Selleck Chemicals Selleck Chemicals TRC TRC
MP Biomedicals -  02153537 external link
Hydrochloride
A sodium ion channel inhibitor.
Selleck Chemicals -  S1811 external link
Research Area: Metabolic Disease
Biological Activity:
Amiloride hydrochloride(Midamor), a pyrazine compound inhibit sodium reabsorption through sodium channels in renal epithelial cells. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with diuretics to spare potassium loss. [1]
Toronto Research Chemicals -  A578700 external link
Sodium channel blocker. Diuretic.

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • http://www.drugbank.ca/drugs/DB00594
  • Paterson, J., et al.: Br. Med. J., 1, 422 (1968)
  • Khan, K., et al.: J. Pharm. Pharmacol., 27, 48 (1968)
  • Frank, S., et al.: J. Pharm. Sci., 64, 1585 (1968)
  • Vidt, D., et al.: Pharmacotherapy, 1, 179 (1968)
  • Cragoe, E.J. et al., J. Med. Chem., 1967, 10, 66, (synth, pharmacol)
  • Smith, R.L. et al., J.A.C.S., 1979, 101, 191, (pmr, cmr, N-15 nmr, tautom)
  • Burns, D.T. et al., Anal. Chim. Acta, 1980, 118, 185, (detn, ClO(-))
  • Hyams, D.E., Int. Congr. Symp. Ser. R. Soc. Med., 1981, 44, 65, (rev)
  • Laragh, J.H., Curr. Ther. Res., 1982, 32, 173, (rev)
  • Martindale, The Extra Pharmacopoeia, 28th/29th edn., Pharmaceutical Press, 1982, 2304
  • Mazzo, D.J., Anal. Profiles Drug Subst., 1986, 15, 1, (rev)
  • Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th edn., Akademie-Verlag, 1987, 445, (synonyms)
  • Amiloride and its Analogs, (eds. Cragoe, E.J. et al), VCH, New York, 1992, (book)
  • Buono, R.A. et al., J.A.C.S., 1994, 116, 1502, (conformn)
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle